Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Building on their success, novel glucagon-like peptide-1 (GLP-1)based therapeutics are rapidly advancing
S., Zhekalov, A
The link between TMAO and MAFLD was first confirmed by a cross sectional observational study conducted by Chen and colleagues, they detected the plasm TMAO levels of healthy people and patients with MAFLD and found that the TMAO level of patients with MAFLD (0.434 M) is 4.17 times higher than that of healthy controls (0.104 M) (Younossi, 2019)
Current Neuropharmacology, 18 (2), 108117
US$ 21.67
US$ 24.25
US$ 23.41
US$ 28.56
US$ 25.08
